Skip to results
Modify your search
NARROW
1-20 of 76
Authors: Adriaan A Voors
Journal Article
Risk calculator of multimorbid risk of rehospitalization and death from heart failure: including the contribution of the gut microbiome Open Access
European Journal of Preventive Cardiology, zwaf270, https://doi.org/10.1093/eurjpc/zwaf270
Published: 28 April 2025
Journal Article
Sex-specific risk factors for new-onset heart failure: the PREVEND study at 25 years Open Access
European Heart Journal, Volume 46, Issue 16, 21 April 2025, Pages 1528–1536, https://doi.org/10.1093/eurheartj/ehae868
Published: 30 December 2024
Journal Article
EDITOR'S CHOICE
GDF15 antagonism limits severe heart failure and prevents cardiac cachexia Open Access
Cardiovascular Research, Volume 120, Issue 17, December 2024, Pages 2249–2260, https://doi.org/10.1093/cvr/cvae214
Published: 23 September 2024
Journal Article
Circulating ECM proteins decorin and alpha-L-iduronidase differentiate ATTRwt-CM from ATTRwt-negative HFpEF/HFmrEF Open Access
Cardiovascular Research, Volume 120, Issue 14, October 2024, Pages 1727–1736, https://doi.org/10.1093/cvr/cvae189
Published: 17 September 2024
Journal Article
Clinical and prognostic associations of autoantibodies recognizing adrenergic/muscarinic receptors in patients with heart failure Open Access
Cardiovascular Research, Volume 119, Issue 8, June 2023, Pages 1690–1705, https://doi.org/10.1093/cvr/cvad042
Published: 08 March 2023
Journal Article
Impact of empagliflozin on decongestion in acute heart failure: the EMPULSE trial Open Access
European Heart Journal, Volume 44, Issue 1, 1 January 2023, Pages 41–50, https://doi.org/10.1093/eurheartj/ehac530
Published: 18 October 2022
Journal Article
Albuminuria as a marker of systemic congestion in patients with heart failure Open Access
European Heart Journal, Volume 44, Issue 5, 1 February 2023, Pages 368–380, https://doi.org/10.1093/eurheartj/ehac528
Published: 23 September 2022
Journal Article
Heart failure medication: moving from evidence generation to implementation Free
European Heart Journal, Volume 43, Issue 27, 14 July 2022, Pages 2588–2590, https://doi.org/10.1093/eurheartj/ehac272
Published: 27 June 2022
Journal Article
Applications of artificial intelligence and machine learning in heart failure Open Access
European Heart Journal - Digital Health, Volume 3, Issue 2, June 2022, Pages 311–322, https://doi.org/10.1093/ehjdh/ztac025
Published: 13 May 2022
Journal Article
128 Clinical impact of changes in mitral regurgitation severity after optimization of medical therapy in heart failure: insights from BIOSTAT-CHF Free
European Heart Journal Supplements, Volume 23, Issue Supplement_G, December 2021, suab139.034, https://doi.org/10.1093/eurheartj/suab139.034
Published: 08 December 2021
Journal Article
Pathophysiological pathways in patients with heart failure and atrial fibrillation Open Access
Cardiovascular Research, Volume 118, Issue 11, July 2022, Pages 2478–2487, https://doi.org/10.1093/cvr/cvab331
Published: 23 October 2021
Journal Article
EDITOR'S CHOICE
Novel biomarker-driven prognostic models to predict morbidity and mortality in chronic heart failure: the EMPEROR-Reduced trial Open Access
European Heart Journal, Volume 42, Issue 43, 14 November 2021, Pages 4455–4464, https://doi.org/10.1093/eurheartj/ehab579
Published: 23 August 2021
Journal Article
Multimarker profiling identifies protective and harmful immune processes in heart failure: findings from BIOSTAT-CHF Open Access
Cardiovascular Research, Volume 118, Issue 8, May 2022, Pages 1964–1977, https://doi.org/10.1093/cvr/cvab235
Published: 15 July 2021
Journal Article
New data on soluble ACE2 in patients with atrial fibrillation reveal potential value for treatment of patients with COVID-19 and cardiovascular disease Free
European Heart Journal, Volume 41, Issue 41, 1 November 2020, Pages 4047–4049, https://doi.org/10.1093/eurheartj/ehaa761
Published: 29 October 2020
Journal Article
EDITOR'S CHOICE
Differences in biomarkers and molecular pathways according to age for patients with HFrEF Free
Cardiovascular Research, Volume 117, Issue 10, 1 September 2021, Pages 2228–2236, https://doi.org/10.1093/cvr/cvaa279
Published: 01 October 2020
Journal Article
The effects of liraglutide and dapagliflozin on cardiac function and structure in a multi-hit mouse model of heart failure with preserved ejection fraction Open Access
Cardiovascular Research, Volume 117, Issue 9, 1 August 2021, Pages 2108–2124, https://doi.org/10.1093/cvr/cvaa256
Published: 01 September 2020
Journal Article
Men more vulnerable to COVID-19: explained by ACE2 on the X chromosome? Open Access
European Heart Journal, Volume 41, Issue 32, 21 August 2020, Page 3096, https://doi.org/10.1093/eurheartj/ehaa526
Published: 24 June 2020
Journal Article
Circulating plasma angiotensin-converting enzyme 2 concentration is elevated in patients with kidney disease and diabetes Open Access
European Heart Journal, Volume 41, Issue 32, 21 August 2020, Page 3099, https://doi.org/10.1093/eurheartj/ehaa527
Published: 20 June 2020
Journal Article
Conducting clinical trials in heart failure during (and after) the COVID-19 pandemic: an Expert Consensus Position Paper from the Heart Failure Association (HFA) of the European Society of Cardiology (ESC) Free
European Heart Journal, Volume 41, Issue 22, 7 June 2020, Pages 2109–2117, https://doi.org/10.1093/eurheartj/ehaa461
Published: 04 June 2020
Journal Article
EDITOR'S CHOICE
Circulating plasma concentrations of angiotensin-converting enzyme 2 in men and women with heart failure and effects of renin–angiotensin–aldosterone inhibitors Open Access
European Heart Journal, Volume 41, Issue 19, 14 May 2020, Pages 1810–1817, https://doi.org/10.1093/eurheartj/ehaa373
Published: 10 May 2020
